Literature DB >> 17442716

The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.

Tamara Utermark1, Brian S Schaffhausen, Thomas M Roberts, Jean J Zhao.   

Abstract

Middle T antigen (MT) of polyomavirus is known to play an important role in virus-mediated cellular transformation. While MT has been extensively examined in spontaneously immortalized rodent fibroblasts, its interactions with cells of other types and species are less well understood. We have undertaken a cross-species and cross-cell-type comparison of MT-induced transformation in cells with genetically defined backgrounds. We tested the transforming abilities of a panel of MT mutants, Y250F, Y315F, and Y322F, that are selectively mutated in the binding sites for the principal effectors of MT--Src homology 2 domain-containing transforming protein, phosphatidylinositol 3-kinase (PI3K), and phospholipase C-gamma, respectively--in fibroblasts and epithelial cells of murine or human origin. We found that the Y315F mutation disabled the ability of MT to induce transformation in all cell types and species tested. While Y315F also failed to activate the PI3K pathway in these cells, genetic evidence has indicated Y315 may make other contributions to transformation. To confirm the role of PI3K, the PIK3CA gene, encoding p110alpha, the prime effector of PI3K signaling downstream from activated growth factor receptors, was genetically ablated. This abolished the transforming activity of MT, demonstrating the essential role for this PI3K isoform in MT-mediated transformation. The Y250F mutant was able to transform the human, but not the murine, cells that were examined. Interestingly, this mutant fully activates the PI3K pathway in human cells but activated PI3K signaling poorly in the murine cells used in the study. This again points to the importance of PI3K activation for transformation and suggests that the mechanism by which MT activates the PI3K pathway differs in different species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442716      PMCID: PMC1933267          DOI: 10.1128/JVI.00115-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  Polyoma virus middle T antigen and its role in identifying cancer-related molecules.

Authors:  Stephen M Dilworth
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

2.  High frequency of mutations of the PIK3CA gene in human cancers.

Authors:  Yardena Samuels; Zhenghe Wang; Alberto Bardelli; Natalie Silliman; Janine Ptak; Steve Szabo; Hai Yan; Adi Gazdar; Steven M Powell; Gregory J Riggins; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-03-11       Impact factor: 47.728

3.  Characterization of polyoma mutants with altered middle and large T-antigens.

Authors:  G Magnusson; M G Nilsson; S M Dilworth; N Smolar
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product?

Authors:  B E Griffin; Y Ito; U Novak; N Spurr; S Dilworth; N Smolar; R Pollack; K Smith; D B Rifkin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

5.  Polyoma virus disrupts ARF signaling to p53.

Authors:  M Lomax; M Fried
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

6.  Phosphorylation of polyoma T antigens.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

7.  ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.

Authors:  S H Ong; S Dilworth; I Hauck-Schmalenberger; T Pawson; F Kiefer
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

8.  A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site.

Authors:  Y Kate Hong; Aki Mikami; Brian Schaffhausen; Toni Jun; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

9.  Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase.

Authors:  Jean J Zhao; Ole V Gjoerup; Romesh R Subramanian; Yuan Cheng; Wen Chen; Thomas M Roberts; William C Hahn
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

10.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein.

Authors:  R Treisman; U Novak; J Favaloro; R Kamen
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

View more
  21 in total

Review 1.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

2.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.

Authors:  Sang Hyun Lee; Shidong Jia; Yanni Zhu; Tamara Utermark; Sabina Signoretti; Massimo Loda; Brian Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

Review 4.  Phosphatidylinositol 3-kinase: the oncoprotein.

Authors:  Peter K Vogt; Jonathan R Hart; Marco Gymnopoulos; Hao Jiang; Sohye Kang; Andreas G Bader; Li Zhao; Adam Denley
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.

Authors:  Tamara Utermark; Fabienne Schmit; Sang Hyun Lee; Xueliang Gao; Brian S Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

7.  SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.

Authors:  Hailing Cheng; Pixu Liu; Zhigang C Wang; Lihua Zou; Stephanie Santiago; Victoria Garbitt; Ole V Gjoerup; J Dirk Iglehart; Alexander Miron; Andrea L Richardson; William C Hahn; Jean J Zhao
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

8.  Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.

Authors:  Kerry A Whalen; Georg F Weber; Thomas L Benjamin; Brian S Schaffhausen
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

Review 9.  Targeting the phosphoinositide 3-kinase pathway in cancer.

Authors:  Pixu Liu; Hailing Cheng; Thomas M Roberts; Jean J Zhao
Journal:  Nat Rev Drug Discov       Date:  2009-08       Impact factor: 84.694

Review 10.  Should individual PI3 kinase isoforms be targeted in cancer?

Authors:  Shidong Jia; Thomas M Roberts; Jean J Zhao
Journal:  Curr Opin Cell Biol       Date:  2009-02-04       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.